Skip to Content
Stock Analyst Update

Pepsi’s Snack Business Helps It Navigate Marketplace

Sales came in at $15.9 billion for the quarter, a 3% year-over-year decline, for the wide-moat company.

Mentioned:

With the second quarter widely expected to be the ugliest for most beverage companies, we think investors had relatively facile expectations heading into wide-moat PepsiCo's (PEP) earnings print and were primarily looking to gauge how the resilience of the snacking business (55% of sales) would offset weakness in soft drinks. The results were comforting in this regard (top- and bottom-line beats relative to CapIQ consensus), and management alluded to a sequential recovery from COVID-19 disruption during the third quarter. We plan to tweak our near-term estimates modestly, but our $140 fair value estimate will not change, and the shares look fully valued to us. Sentiment around wide-moat Coca-Cola’s stock has been less constructive due to its pure-play beverage exposure, but despite a more precarious near-term outlook, we still see a more compelling long-term risk/reward opportunity in Big Red’s shares.

Sales came in at $15.9 billion for the quarter, a 3% year-over-year decline. Organic revenue, however, was roughly flat, an impressive feat reflecting a booming snack business (up 5% globally with brands like Tostitos and Cheetos growing double-digits) juxtaposed against weak beverage performance (down 7%, with on-premises restrictions more than offsetting strong traditional retail sales). Headline Latin America revenue (a 17% decline) reflected currency headwinds and belied the region’s relatively healthy organic sales (which were flat). A predominantly snack food business, Pepsi’s Latin American operations are well suited for this environment due to less on-premises exposure and more containment-induced consumption occasions (whether for breakfast, snacking, dinner, or the like). Nevertheless, we’ll keep a close eye on how this business holds up, given the socioeconomic realities of the region (which have been exacerbated by COVID-19) and fundamentally different go-to-market dynamics.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Nicholas Johnson does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.